Found: 15
Select item for more details and to access through your institution.
Extrahepatic Obstructive Jaundice Due to Colorectal Cancer.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 1988, v. 83, n. 3, p. 267
- By:
- Publication type:
- Article
Renal failure due to lymphomatous infiltration of the kidneys. Report of three new cases and review of the literature.
- Published in:
- 1986
- By:
- Publication type:
- journal article
A dose escalation/expansion study evaluating dose, safety, and efficacy of the novel tyrosine kinase inhibitor surufatinib, which inhibits VEGFR 1, 2, & 3, FGFR 1, and CSF1R, in US patients with neuroendocrine tumors.
- Published in:
- Investigational New Drugs, 2023, v. 41, n. 3, p. 421, doi. 10.1007/s10637-023-01359-2
- By:
- Publication type:
- Article
Phase II Trial of Concurrent Sunitinib and Image-Guided Radiotherapy for Oligometastases.
- Published in:
- PLoS ONE, 2012, v. 7, n. 6, p. e36979, doi. 10.1371/journal.pone.0036979
- By:
- Publication type:
- Article
A Phase 1b Study of Lenvatinib plus Pembrolizumab in Patients with Unresectable Hepatocellular Carcinoma: Extended Analysis of Study 116.
- Published in:
- Liver Cancer (2235-1795), 2024, v. 13, n. 4, p. 451, doi. 10.1159/000535154
- By:
- Publication type:
- Article
Correction: Urine protein:creatinine ratio vs 24-hour urine protein for proteinuria management: analysis from the phase 3 REFLECT study of lenvatinib vs sorafenib in hepatocellular carcinoma.
- Published in:
- 2019
- By:
- Publication type:
- corrected article
Urine protein:creatinine ratio vs 24-hour urine protein for proteinuria management: analysis from the phase 3 REFLECT study of lenvatinib vs sorafenib in hepatocellular carcinoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Concurrent sunitinib and stereotactic body radiotherapy for patients with oligometastases: final report of a prospective clinical trial.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Fractionated radioimmunotherapy with <sup>90</sup>Y-clivatuzumab tetraxetan and low-dose gemcitabine is active in advanced pancreatic cancer.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 22, p. 5497, doi. 10.1002/cncr.27592
- By:
- Publication type:
- Article
Erratum: Phase 1 study of concurrent sunitinib and image-guided radiotherapy followed by maintenance sunitinib for patients with oligometastases.
- Published in:
- 2011
- By:
- Publication type:
- Erratum
Phase 1 Study of Concurrent Sunitinib and Image-Guided Radiotherapy Followed by Maintenance Sunitinib for Patients With Oligometastases.
- Published in:
- Cancer (0008543X), 2009, v. 115, n. 15, p. 3571, doi. 10.1002/cncr.24412
- By:
- Publication type:
- Article
Phase 1 study of concurrent sunitinib and image-guided radiotherapy followed by maintenance sunitinib for patients with oligometastases: acute toxicity and preliminary response.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Chronic Thalidomide and Chemoembolization for Hepatocellular Carcinoma.
- Published in:
- Oncologist, 2014, v. 19, n. 12, p. 1229, doi. 10.1634/theoncologist.2014-0283
- By:
- Publication type:
- Article
Association between treatment‐emergent hypertension and survival with lenvatinib treatment for patients with hepatocellular carcinoma in the REFLECT study.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 8, p. 1281, doi. 10.1002/cncr.35185
- By:
- Publication type:
- Article
Classification for long-term survival in oligometastatic patients treated with ablative radiotherapy: A multi-institutional pooled analysis.
- Published in:
- PLoS ONE, 2018, v. 13, n. 4, p. 1, doi. 10.1371/journal.pone.0195149
- By:
- Publication type:
- Article